Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31435 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Juri Iwata and 15 co-authors. Institution: Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. Major MEDLINE topics: Transcatheter Aortic Valve Replacement, Thrombosis, Multidetector Computed Tomography, Aortic Valve. Cited 3 times so far (Crossref); 16 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long‐term clinical outcomes remains unclear. This study aimed to investigate the impact of early HALT detection after TAVI on long‐term clinical outcomes and structural valve deterioration beyond 6 years.
Methods
Of the 672 consecutive patients who underwent TAVI between 2013 and 2018, 448 were treated with either SAPIEN XT or SAPIEN 3 and underwent MDCT analysis within 30 days after TAVI. MDCT results and echocardiographic data were analyzed annually.
Results
HALT was detected in 68 (15.2%) of 448 eligible patients within 30 days after TAVI. No significant difference in effective orifice area was observed by echocardiography within 30 days after TAVI between the HALT and the non‐HALT groups in SAPIEN XT (HALT vs. non‐HALT: 1.62 ± 0.66 cm 2 vs. 1.72 ± 0.43 cm 2 ; p = 0.26) and in SAPIEN 3 (1.42 ± 0.35 cm 2 vs. 1.45 ± 0.34 cm 2 ; p = 0.63). No significant differences in all‐cause mortality (52.9% vs. 60.0%; hazard ratio (HR): 1.19; 95% confidence interval (CI): 0.83−1.70; p = 0.3), stroke incidence (5.9% vs. 7.1%; HR: 1.06; 95% CI: 0.08−13.7; p = 0.97), heart failure rehospitalization (10.3% vs. 15.0%; HR: 2.3; 95% CI: 0.89−5.99; p = 0.09), and structural valve deterioration (14.7% vs. 17.9%; HR: 0.89; 95% CI: 0.45−1.73; p = 0.73) were observed between the HALT and the non‐HALT groups during the median follow‐up of 1872 (interquartile range; 1203−2468) days.
Conclusions
HALT within 30 days was not associated with clinical outcomes or hemodynamic performance during long‐term follow‐up.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
- Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
- Department of Anesthesiology, Keio University School of Medicine, Tokyo, Japan.
- Department of Cardiovascular Surgery, Keio University School of Medicine, Tokyo, Japan.
ORCID profiles: Juri Iwata, Kentaro Hayashida
Funding
- The authors received no specific funding for this work.
Cite
APA
Iwata, J., Hayashida, K., Arita, R., Moriizumi, T., Kajino, A., Sakata, S., Ryuzaki, T., Shinada, K., Tsuruta, H., Yamada, Y., Kato, J., Takahashi, T., Yamazaki, M., Jinzaki, M., Shimizu, H., & Ieda, M. (2025). Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31435
Vancouver
Iwata J, Hayashida K, Arita R, Moriizumi T, Kajino A, Sakata S, et al. Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31435
BibTeX
@article{Iwata2025,
author = {Iwata, Juri and Hayashida, Kentaro and Arita, Ryo and Moriizumi, Tomonari and Kajino, Akiyoshi and Sakata, Shingo and Ryuzaki, Toshinobu and Shinada, Keitaro and Tsuruta, Hikaru and Yamada, Yoshitake and Kato, Jungo and Takahashi, Tatsuo and Yamazaki, Masataka and Jinzaki, Masahiro and Shimizu, Hideyuki and Ieda, Masaki},
title = {Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31435}
}
EUVIMED